Cargando…

Can spectral computed tomography (CT) replace perfusion CT to assess the histological classification of non-small cell lung cancer?

BACKGROUND: Non-small cell lung cancer (NSCLC) accounts for 80% of total lung cancer cases, it is necessary to distinguish the histological types of NSCLC. This study set out to investigate the correlation between spectral computed tomography (CT) and CT perfusion parameters in patients with NSCLC a...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Liangna, Yang, Jingjing, Ren, Tiezhu, Jing, Mengyuan, Han, Tao, Zhang, Bin, Zhou, Junlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423375/
https://www.ncbi.nlm.nih.gov/pubmed/37581057
http://dx.doi.org/10.21037/qims-22-1206
_version_ 1785089435513126912
author Deng, Liangna
Yang, Jingjing
Ren, Tiezhu
Jing, Mengyuan
Han, Tao
Zhang, Bin
Zhou, Junlin
author_facet Deng, Liangna
Yang, Jingjing
Ren, Tiezhu
Jing, Mengyuan
Han, Tao
Zhang, Bin
Zhou, Junlin
author_sort Deng, Liangna
collection PubMed
description BACKGROUND: Non-small cell lung cancer (NSCLC) accounts for 80% of total lung cancer cases, it is necessary to distinguish the histological types of NSCLC. This study set out to investigate the correlation between spectral computed tomography (CT) and CT perfusion parameters in patients with NSCLC and to compare the differential diagnostic efficacy of these two imaging modalities for the histological classification of NSCLC. METHODS: A total of 62 eligible consecutive patients, including 32 with lung adenocarcinoma (LUAD) and 30 with lung squamous cell carcinoma (LUSC), who underwent “one-stop” spectral combined perfusion scan and pathologically confirmed NSCLC at Lanzhou University Second Hospital between September 2020 and December 2021 were prospectively enrolled. The spectral parameters of lesions in the arterial phase (AP) and venous phase (VP) [including iodine concentration (IC), effective atomic number (Zeff), CT(40keV), and slope of the spectral curve (K(70keV))] and perfusion parameters [blood flow (BF), blood volume (BV), surface permeability (PS), and mean transit time (MTT)] were assessed. Pearson or Spearman correlation analysis was performed to evaluate the correlation between the two imaging parameters, and the DeLong test was used to compare the diagnostic performance of the two imaging modalities. RESULTS: BV and BF were strongly correlated with spectral parameters CT(40keV), IC, Zeff, and K(70keV) in the AP and VP (0.6<r<0.8, P<0.001). MTT was moderately correlated with the above spectral parameters in the AP and VP (0.4<r<0.6, P<0.001). PS was weakly correlated with the above spectral parameters in the VP (0.2<r<0.4, P<0.05). The DeLong test revealed a statistical difference between the area under the curve (AUC) of spectral CT (AUC =0.93, 95% CI: 0.86–0.99, sensitivity =0.94, specificity =0.83) and perfusion CT (AUC =0.81, 95% CI: 0.70–0.92, sensitivity =0.99, specificity =0.57) (P<0.05). CONCLUSIONS: Spectral parameters are significantly correlated with perfusion parameters in NSCLC, and spectral CT has a better diagnostic efficacy than perfusion CT in differentiating the histological classification of NSCLC.
format Online
Article
Text
id pubmed-10423375
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-104233752023-08-14 Can spectral computed tomography (CT) replace perfusion CT to assess the histological classification of non-small cell lung cancer? Deng, Liangna Yang, Jingjing Ren, Tiezhu Jing, Mengyuan Han, Tao Zhang, Bin Zhou, Junlin Quant Imaging Med Surg Original Article BACKGROUND: Non-small cell lung cancer (NSCLC) accounts for 80% of total lung cancer cases, it is necessary to distinguish the histological types of NSCLC. This study set out to investigate the correlation between spectral computed tomography (CT) and CT perfusion parameters in patients with NSCLC and to compare the differential diagnostic efficacy of these two imaging modalities for the histological classification of NSCLC. METHODS: A total of 62 eligible consecutive patients, including 32 with lung adenocarcinoma (LUAD) and 30 with lung squamous cell carcinoma (LUSC), who underwent “one-stop” spectral combined perfusion scan and pathologically confirmed NSCLC at Lanzhou University Second Hospital between September 2020 and December 2021 were prospectively enrolled. The spectral parameters of lesions in the arterial phase (AP) and venous phase (VP) [including iodine concentration (IC), effective atomic number (Zeff), CT(40keV), and slope of the spectral curve (K(70keV))] and perfusion parameters [blood flow (BF), blood volume (BV), surface permeability (PS), and mean transit time (MTT)] were assessed. Pearson or Spearman correlation analysis was performed to evaluate the correlation between the two imaging parameters, and the DeLong test was used to compare the diagnostic performance of the two imaging modalities. RESULTS: BV and BF were strongly correlated with spectral parameters CT(40keV), IC, Zeff, and K(70keV) in the AP and VP (0.6<r<0.8, P<0.001). MTT was moderately correlated with the above spectral parameters in the AP and VP (0.4<r<0.6, P<0.001). PS was weakly correlated with the above spectral parameters in the VP (0.2<r<0.4, P<0.05). The DeLong test revealed a statistical difference between the area under the curve (AUC) of spectral CT (AUC =0.93, 95% CI: 0.86–0.99, sensitivity =0.94, specificity =0.83) and perfusion CT (AUC =0.81, 95% CI: 0.70–0.92, sensitivity =0.99, specificity =0.57) (P<0.05). CONCLUSIONS: Spectral parameters are significantly correlated with perfusion parameters in NSCLC, and spectral CT has a better diagnostic efficacy than perfusion CT in differentiating the histological classification of NSCLC. AME Publishing Company 2023-05-31 2023-08-01 /pmc/articles/PMC10423375/ /pubmed/37581057 http://dx.doi.org/10.21037/qims-22-1206 Text en 2023 Quantitative Imaging in Medicine and Surgery. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Deng, Liangna
Yang, Jingjing
Ren, Tiezhu
Jing, Mengyuan
Han, Tao
Zhang, Bin
Zhou, Junlin
Can spectral computed tomography (CT) replace perfusion CT to assess the histological classification of non-small cell lung cancer?
title Can spectral computed tomography (CT) replace perfusion CT to assess the histological classification of non-small cell lung cancer?
title_full Can spectral computed tomography (CT) replace perfusion CT to assess the histological classification of non-small cell lung cancer?
title_fullStr Can spectral computed tomography (CT) replace perfusion CT to assess the histological classification of non-small cell lung cancer?
title_full_unstemmed Can spectral computed tomography (CT) replace perfusion CT to assess the histological classification of non-small cell lung cancer?
title_short Can spectral computed tomography (CT) replace perfusion CT to assess the histological classification of non-small cell lung cancer?
title_sort can spectral computed tomography (ct) replace perfusion ct to assess the histological classification of non-small cell lung cancer?
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423375/
https://www.ncbi.nlm.nih.gov/pubmed/37581057
http://dx.doi.org/10.21037/qims-22-1206
work_keys_str_mv AT dengliangna canspectralcomputedtomographyctreplaceperfusioncttoassessthehistologicalclassificationofnonsmallcelllungcancer
AT yangjingjing canspectralcomputedtomographyctreplaceperfusioncttoassessthehistologicalclassificationofnonsmallcelllungcancer
AT rentiezhu canspectralcomputedtomographyctreplaceperfusioncttoassessthehistologicalclassificationofnonsmallcelllungcancer
AT jingmengyuan canspectralcomputedtomographyctreplaceperfusioncttoassessthehistologicalclassificationofnonsmallcelllungcancer
AT hantao canspectralcomputedtomographyctreplaceperfusioncttoassessthehistologicalclassificationofnonsmallcelllungcancer
AT zhangbin canspectralcomputedtomographyctreplaceperfusioncttoassessthehistologicalclassificationofnonsmallcelllungcancer
AT zhoujunlin canspectralcomputedtomographyctreplaceperfusioncttoassessthehistologicalclassificationofnonsmallcelllungcancer